NEW ORLEANS — In a move signaling a renewed commitment to research-driven innovation and global clinical advancement, The Plastic Surgery Foundation (The PSF) has announced the appointment of Dr. Babak J. Mehrara as its new president. Dr. Mehrara, a distinguished figure in the field of oncologic reconstruction and a renowned expert in lymphatic biology, officially assumed his leadership role on October 12, 2025, during Plastic Surgery The Meeting, the annual flagship conference of the American Society of Plastic Surgeons (ASPS), held in New Orleans.
His appointment marks a pivotal moment for The PSF, which serves as the philanthropic and research-supporting arm of the ASPS. Dr. Mehrara will serve a one-year term, concluding on October 18, 2026, during which he intends to reshape the landscape of plastic and reconstructive surgery through a rigorous focus on scientific inquiry and the mentorship of the next generation of surgeons.
Main Facts: A New Chapter for The PSF
The PSF functions as a critical nexus for the plastic surgery profession, providing the grants, educational infrastructure, and international outreach programs necessary to advance the specialty. As president, Dr. Mehrara is responsible for overseeing the strategic direction of these initiatives.
His background is uniquely suited for this role. Currently serving as the Chief of the Plastic and Reconstructive Surgery Service at Memorial Sloan Kettering Cancer Center (MSK), Dr. Mehrara occupies the prestigious Peter G. Cordeiro Endowed Chair in the Department of Surgery. His clinical practice focuses on the complex intersection of oncologic resection and subsequent reconstruction, a field where precision and innovation are not merely desired but essential for patient outcomes.
The transition of power was formalized at the ASPS annual gathering, where Dr. Mehrara addressed a global audience of surgeons, researchers, and industry stakeholders. His platform for the upcoming year rests on three pillars: accelerating high-impact clinical research, expanding global access to safe reconstructive care, and fostering a robust ecosystem for early-career investigators.
Chronology of Leadership and Innovation
The trajectory of Dr. Mehrara’s career reflects a steady climb toward the pinnacle of surgical science. His journey is defined by a consistent pursuit of both the operating room and the laboratory.
- Academic Foundations: After completing his surgical training, Dr. Mehrara committed himself to the academic rigor of institutional medicine, eventually joining the faculty at Weill Cornell Medical College as a Professor of Surgery.
- Scientific Breakthroughs: Over the past two decades, Dr. Mehrara has dedicated his career to the study of lymphatic diseases. His leadership of the Lymphatic Biology Laboratory at MSK, funded by the National Institutes of Health (NIH), has resulted in over 400 peer-reviewed publications. This body of work has fundamentally altered how the medical community understands and treats cancer-related lymphedema.
- Institutional Stewardship: His rise within the hierarchy of Memorial Sloan Kettering culminated in his appointment as Chief of the Plastic and Reconstructive Surgery Service. This role cemented his reputation as an administrator capable of balancing high-volume clinical output with groundbreaking research.
- The PSF Transition (2025): Following years of service within the ASPS and associated scientific committees, Dr. Mehrara was elected to the presidency of The PSF. His term officially commenced on October 12, 2025, in New Orleans, setting the stage for a year of organizational evolution.
Supporting Data: The Impact of Evidence-Based Surgery
To understand why Dr. Mehrara is considered a transformative choice for The PSF, one must examine the metrics of his scientific output. In the realm of academic medicine, influence is often measured by the volume and citation count of peer-reviewed research. With over 400 publications, Dr. Mehrara’s contributions have been foundational to the development of modern lymphedema treatment protocols.
The Lymphatic Biology Laboratory
The NIH-funded research under Dr. Mehrara’s direction does more than produce papers; it provides the empirical evidence necessary for surgical policy changes. By investigating the molecular mechanisms of lymphatic failure, his team has helped transition lymphedema treatment from palliative management to curative-intent surgical interventions.
Financial and Educational Support
The PSF manages millions of dollars in research grants annually. Under the guidance of an expert who understands the hurdles of securing NIH funding, the Foundation is expected to refine its grant-making process to better support "high-risk, high-reward" research projects. By targeting early-career researchers, Dr. Mehrara aims to solve the "valley of death" often seen in medical innovation, where promising research fails to secure the funding necessary for clinical translation.
Official Responses: A Vision for the Future
During his inaugural address, Dr. Mehrara emphasized the duality of his mission: honoring the legacy of the Foundation while aggressively pursuing new frontiers.
"It’s an honor to lead The PSF, and I look forward to building on its legacy of excellence in plastic surgery research and innovation," Dr. Mehrara stated. "I am deeply committed to the advancement of scientific discovery and supporting the work of residents, early-career researchers, and emerging innovators. Throughout my presidency, I will champion new ways to strengthen and expand The Foundation’s mission of research and education."
Colleagues within the ASPS and MSK have lauded the appointment, noting that Dr. Mehrara’s ability to communicate complex scientific concepts makes him an ideal ambassador for the specialty. His emphasis on "meaningful clinical advances" suggests a departure from theoretical research toward projects that have an immediate, tangible impact on patient safety and quality of life.
Implications for the Field of Plastic Surgery
The presidency of Dr. Mehrara is poised to have several long-term implications for the specialty of plastic and reconstructive surgery.
1. The Professionalization of Research
As the cost of medical education rises and clinical demands grow, many surgeons find it difficult to maintain active research portfolios. Dr. Mehrara’s term is expected to prioritize infrastructure for clinician-scientists. By leveraging his connections with the NIH and other funding bodies, he plans to create a more sustainable model for research within private and academic practice settings.
2. Focus on Global Health Equity
While The PSF has historically focused on domestic education, there is an increasing push to expand access to "safe, effective, and affordable" plastic surgery care internationally. Dr. Mehrara’s vision includes building partnerships that facilitate the export of advanced reconstructive techniques to resource-limited settings. This is a critical move, as oncologic reconstruction is often the most neglected aspect of cancer care in developing nations.
3. The Shift Toward Specialized Reconstruction
Under his leadership, the Foundation is likely to increase its funding for sub-specialized fields, such as lymphatic surgery and advanced microsurgery. By focusing on these high-complexity areas, The PSF intends to establish itself as the premier source for clinical guidelines and standardized surgical training, ensuring that the latest techniques are disseminated rapidly to surgeons worldwide.
4. Mentorship and the Next Generation
A recurring theme in Dr. Mehrara’s career is the mentorship of residents. By creating new fellowship opportunities and research forums, he intends to ensure that the "pipeline" of talent remains robust. His focus is on fostering an environment where residents feel empowered to challenge existing surgical paradigms.
Conclusion: A Legacy in the Making
As Dr. Babak J. Mehrara begins his tenure as president of The Plastic Surgery Foundation, the medical community looks on with high expectations. His dual identity as a high-level surgeon and a rigorous scientist provides a unique vantage point from which to address the challenges facing modern reconstructive medicine.
The next twelve months will be defined by his ability to translate his laboratory successes into organizational policy. Whether through the development of new educational platforms or the strategic allocation of research capital, Dr. Mehrara is set to leave an indelible mark on the profession. As the landscape of oncology and reconstructive surgery continues to evolve, the leadership of The PSF remains in steady, highly capable hands, ensuring that the future of the specialty remains rooted in science, innovation, and, above all, the pursuit of patient-centered excellence.
About the Author
